These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 9674632)

  • 21. Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension.
    Lombardo M; Alli C; Broccolino M; Ferrari S; Montemurro L; Zaini G; Zanni D
    Am Heart J; 1997 Sep; 134(3):557-64. PubMed ID: 9327716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of endothelial function by amlodipine and vitamin C in essential hypertension.
    On YK; Kim CH; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Korean J Intern Med; 2002 Jun; 17(2):131-7. PubMed ID: 12164090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure.
    Kakoki M; Hirata Y; Hayakawa H; Suzuki E; Nagata D; Nishimatsu H; Kimura K; Goto A; Omata M
    Hypertens Res; 2000 Sep; 23(5):527-33. PubMed ID: 11016809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
    Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of L-arginine infusion on renal hemodynamics in patients with mild essential hypertension.
    Higashi Y; Oshima T; Ozono R; Watanabe M; Matsuura H; Kajiyama G
    Hypertension; 1995 Apr; 25(4 Pt 2):898-902. PubMed ID: 7721451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
    Nakamura T; Inoue T; Suzuki T; Kawagoe Y; Ueda Y; Koide H; Node K
    Hypertens Res; 2008 May; 31(5):841-50. PubMed ID: 18712038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway.
    Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG
    Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension.
    He Y; Si D; Yang C; Ni L; Li B; Ding M; Yang P
    Am J Hypertens; 2014 Jan; 27(1):27-31. PubMed ID: 23959544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney.
    Tojo A; Kobayashi N; Kimura K; Hirata Y; Matsuoka H; Yagi S; Omata M
    Kidney Int Suppl; 1996 Jun; 55():S138-40. PubMed ID: 8743536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Felmeden DC; Blann AD; Lip GY
    Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM; Schaefer A
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect.
    Watanabe Y; Takasugi E; Shitakura K; Okajima K; Hota N; Kubo Y; Nunoda S; Otsuka K
    Clin Exp Hypertens; 2011; 33(4):246-54. PubMed ID: 21699451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.
    Honda A; Tahara N; Tahara A; Bekki M; Maeda-Ogata S; Sugiyama Y; Igata S; Nishino Y; Matsui T; Kurata S; Abe T; Yamagishi SI; Fukumoto Y
    J Nucl Cardiol; 2023 Aug; 30(4):1613-1626. PubMed ID: 36737518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different effect of antihypertensive drugs on conduit artery endothelial function.
    Ghiadoni L; Magagna A; Versari D; Kardasz I; Huang Y; Taddei S; Salvetti A
    Hypertension; 2003 Jun; 41(6):1281-6. PubMed ID: 12719441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
    Messerli FH; Oparil S; Feng Z
    Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
    Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study.
    Kumagai H; Hayashi K; Kumamaru H; Saruta T
    Am J Hypertens; 2000 Sep; 13(9):980-5. PubMed ID: 10981547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.